264
Thirty - five consecutive chemotherapy - naive patients with Stage IV NSCLC and an Eastern Cooperative Oncology Group performance status of 0 - 2 were treated with a combination of paclitaxel ( 135 mg / m ( 2 ) given intravenously in 3 hours ) on Day 1 , cisplatin ( 120 mg / m ( 2 ) given intravenously in 6 hours ) on Day 1 , and gemcitabine ( 800 mg / m ( 2 ) given intravenously in 30 minutes ) on Days 1 and 8 , every 4 weeks .
 Disease: NSCLC; Chemical: paclitaxel; Chemical: cisplatin; Chemical: gemcitabine
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
 Entities: NSCLC, paclitaxel, cisplatin, gemcitabine 
Answer:
 Disease: NSCLC; Chemical: paclitaxel; Chemical: cisplatin; Chemical: gemcitabine